Marine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials

Progress in the Chemistry of Organic Natural Products 109

(2019) · Progress in the Chemistry of Organic Natural Products · doi:10.1007/978-3-030-12858-6 · Cited by 2,052

The influence of natural products upon drug discovery (Antiquity to late 1999)

Newman, D. J., Cragg, G. M., & Snader, K. M. (2000) · Natural Product Reports · doi:10.1039/a902202c · Cited by 1,293

Chemistry and Biology of the Tetrahydroisoquinoline Antitumor Antibiotics

Scott, J. D., & Williams, R. M. (2002) · Chemical Reviews · doi:10.1021/cr010212u · Cited by 1,149

Intrathecal Ziconotide in the Treatment of Refractory Pain in Patients With Cancer or AIDS: A Randomized Controlled Trial

Staats, P. S., Yearwood, T., Charapata, S. G., Presley, R. W., Wallace, M. S., Byas-Smith, M., Fisher, R., Bryce, D. A., Mangieri, E. A., Luther, R. R., et al. (2004) · JAMA · doi:10.1001/jama.291.1.63 · Cited by 654

A polyketide synthase-peptide synthetase gene cluster from an uncultured bacterial symbiont of Paederus beetles

Piel, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222481399 · Cited by 609

Halichondrins-antitumor polyether macrolides from a marine sponge

Hirata, Y., & Uemura, D. (1986) · Pure and Applied Chemistry · doi:10.1351/pac198658050701 · Cited by 519

Ecteinascidins 729, 743, 745, 759A, 759B, and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata

Rinehart, K. L., Holt, T. G., Fregeau, N. L., Stroh, J. G., Keifer, P. A., Sun, F., Li, L. H., & Martin, D. G. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00302a007 · Cited by 492

Marine natural products and their potential applications as anti-infective agents

Donia, M., & Hamann, M. T. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00655-8 · Cited by 425

Total synthesis of halichondrin B and norhalichondrin B

Aicher, T. D., Buszek, K. R., Fang, F. G., Forsyth, C. J., Jung, S. H., Kishi, Y., Matelich, M. C., Scola, P. M., Spero, D. M., & Yoon, S. K. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00034a086 · Cited by 400

Agelasphins, novel antitumor and immunostimulatory cerebrosides from the marine sponge Agelas mauritianus

Natori, T., Morita, M., Akimoto, K., & Koezuka, Y. (1994) · Tetrahedron · doi:10.1016/s0040-4020(01)86991-x · Cited by 397

Structure of curacin A, a novel antimitotic, antiproliferative and brine shrimp toxic natural product from the marine cyanobacterium Lyngbya majuscula

Gerwick, W. H., Proteau, P. J., Nagle, D. G., Hamel, E., Blokhin, A., & Slate, D. L. (1994) · The Journal of Organic Chemistry · doi:10.1021/jo00085a006 · Cited by 365

Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair

Takebayashi, Y., Pourquier, P., Zimonjic, D. B., Nakayama, K., Emmert, S., Ueda, T., Urasaki, Y., Kanzaki, A., Akiyama, S.-I., Popescu, N., et al. (2001) · Nature Medicine · doi:10.1038/91008 · Cited by 348

Isolation and structure determination of diazonamides A and B, unusual cytotoxic metabolites from the marine ascidian Diazona chinensis

Lindquist, N., Fenical, W., Duyne, G. D. V., & Clardy, J. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00006a060 · Cited by 343

Total structures of cryptophycins, potent antitumor depsipeptides from the blue-green alga Nostoc sp. strain GSV 224

Trimurtulu, G., Ohtani, I., Patterson, G. M. L., Moore, R. E., Corbett, T. H., Valeriote, F. A., & Demchik, L. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00090a020 · Cited by 303

A G-Quadruplex-Interactive Potent Small-Molecule Inhibitor of Telomerase Exhibiting in Vitro and in Vivo Antitumor Activity

Gowan, S. M., Harrison, J. R., Patterson, L., Valenti, M., Read, M. A., Neidle, S., & Kelland, L. R. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12212-2 · Cited by 303

Eleutherobin, a New Cytotoxin that Mimics Paclitaxel (Taxol) by Stabilizing Microtubules

Lindel, T., Jensen, P. R., Fenical, W., Long, B. H., Casazza, A. M., Carboni, J., & Fairchild, C. R. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9717828 · Cited by 293

Norhalichondrin A: an antitumor polyether macrolide from a marine sponge

Uemura, D., Takahashi, K., Yamamoto, T., Katayama, C., Tanaka, J., Okumura, Y., & Hirata, Y. (1985) · Journal of the American Chemical Society · doi:10.1021/ja00302a042 · Cited by 289

Synthesis of Ecteinascidin ET-743 and Phthalascidin Pt-650 from Cyanosafracin B

Cuevas, C., Pérez, M., Martín, M. J., Chicharro, J. L., Fernández-Rivas, C., Flores, M., Francesch, A., Gallego, P., Zarzuelo, M., de la Calle, F., et al. (2000) · Organic Letters · doi:10.1021/ol0062502 · Cited by 282

Manoalide, an antibiotic sesterterpenoid from the marine sponge (polejaeff)

de Silva, E. D., & Scheuer, P. J. (1980) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)77766-5 · Cited by 277

Evidence for the Biosynthesis of Bryostatins by the Bacterial Symbiont “ Candidatus Endobugula sertula” of the Bryozoan Bugula neritina

Davidson, S. K., Allen, S. W., Lim, G. E., Anderson, C. M., & Haygood, M. G. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.10.4531-4537.2001 · Cited by 275

Antitumor tetrahydroisoquinoline alkaloids from the colonial ascidian Ecteinascidia turbinata

Wright, A. E., Forleo, D. A., Gunawardana, G. P., Gunasekera, S. P., Koehn, F. E., & McConnell, O. J. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00302a006 · Cited by 268

Salicylihalamides A and B, Novel Cytotoxic Macrolides from the Marine Sponge Haliclona sp.

Erickson, K. L., Beutler, J. A., Cardellina, J. H., & Boyd, M. R. (1997) · The Journal of Organic Chemistry · doi:10.1021/jo971556g · Cited by 255

Agelasphins, novel α-galactosylceramides from the marine sponge Agelas mauritianus

Natori, T., Koezuka, Y., & Higa, T. (1993) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)73889-5 · Cited by 253

Kahalalides: Bioactive Peptides from a Marine Mollusk Elysia rufescens and Its Algal Diet Bryopsis sp. 1

Hamann, M. T., Otto, C. S., Scheuer, P. J., & Dunbar, D. C. (1996) · The Journal of Organic Chemistry · doi:10.1021/jo960877+ · Cited by 240

Kahalalide F: a bioactive depsipeptide from the sacoglossan mollusk Elysia rufescens and the green alga Bryopsis sp

Hamann, M. T., & Scheuer, P. J. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00066a061 · Cited by 237

Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere

Krohn, A., Redshaw, S., Ritchie, J. C., Graves, B. J., & Hatada, M. H. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00115a028 · Cited by 233

Synthesis of bryostatin 7

Kageyama, M., Tamura, T., Nantz, M. H., Roberts, J. C., Somfai, P., Whritenour, D. C., & Masamune, S. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00176a058 · Cited by 230

Thiocoraline, a New Depsipeptide with Antitumor Activity Produced by a Marine Micromonospora. I. Taxonomy, Fermentation, Isolation, and Biological Activities.

ROMERO, F., ESPLIEGO, F., BAZ, J. P., QUESADA, T. G. D., GRÁVALOS, D., CALLE, F. D. L., & FERNÁNDEZ-PUENTES, J. L. (1997) · The Journal of Antibiotics · doi:10.7164/antibiotics.50.734 · Cited by 225

NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma

Catley, L., Weisberg, E., Tai, Y.-T., Atadja, P., Remiszewski, S., Hideshima, T., Mitsiades, N., Shringarpure, R., LeBlanc, R., Chauhan, D., et al. (2003) · Blood · doi:10.1182/blood-2003-01-0233 · Cited by 216

Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C.

Wender, P. A., Cribbs, C. M., Koehler, K. F., Sharkey, N. A., Herald, C. L., Kamano, Y., Pettit, G. R., & Blumberg, P. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.19.7197 · Cited by 201

Antineoplastic agents. 219. Isolation and structure of the cell growth inhibitory constituents from the western Pacific marine sponge Axinella sp

Pettit, G. R., Herald, C. L., Boyd, M. R., Leet, J. E., Dufresne, C., Doubek, D. L., Schmidt, J. M., Cerny, R. L., Hooper, J. N. A., & Rutzler, K. C. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00115a027 · Cited by 191

Structure determination, conformational analysis, chemical stability studies, and antitumor evaluation of the cryptophycins. isolation of 18 new analogs from nostoc sp. strain GSV 224

Golakoti, T., Ogino, J., Heltzel, C. E., Le Husebo, T., Jensen, C. M., Larsen, L. K., Patterson, G. M. L., Moore, R. E., Mooberry, S. L., Corbett, T. H., et al. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00154a002 · Cited by 186

Natural products which interact with tubulin in the vinca domain: Maytansine, rhizoxin, phomopsin a, dolastatins 10 and 15 and halichondrin B

Hamel, E. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90028-x · Cited by 186

Chemistry and clinical biology of the bryostatins

Mutter, R., & Wills, M. (2000) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00150-4 · Cited by 178

Alkaloids from the antarctic sponge Kirkpatrickia varialosa.

Perry, N. B., Ettouati, L., Litaudon, M., Blunt, J. W., Munro, M. H. G., Parkin, S., & Hope, H. (1994) · Tetrahedron · doi:10.1016/s0040-4020(01)89673-3 · Cited by 176

Total Synthesis of Bryostatin 3

Ohmori, K., Ogawa, Y., Obitsu, T., Ishikawa, Y., Nishiyama, S., & Yamamura, S. (2000) · Angewandte Chemie International Edition · Cited by 168

A MAP kinase-dependent actin checkpoint ensures proper spindle orientation in fission yeast

Gachet, Y., Tournier, S., Millar, J. B. A., & Hyams, J. S. (2001) · Nature · doi:10.1038/35085604 · Cited by 161

Natural Products and Derivatives as Leads to Cell Cycle Pathway Targets in Cancer Chemotherapy

Newman, D., Cragg, G., Holbeck, S., & Sausville, E. (2002) · Current Cancer Drug Targets · doi:10.2174/1568009023333791 · Cited by 160

α-Galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis

Hayakawa, Y., Rovero, S., Forni, G., & Smyth, M. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630663100 · Cited by 158

Cytotoxic peptides from the marine sponge Cymbastela sp.

Coleman, J. E., de Silva, E. D., Kong, F., et al. (1995) · Tetrahedron · doi:10.1016/0040-4020(95)00646-p · Cited by 157

Analysis of the phorbol ester pharmacophore on protein kinase C as a guide to the rational design of new classes of analogs.

Wender, P. A., Koehler, K. F., Sharkey, N. A., et al. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4214 · Cited by 157

AplidinTM Induces Apoptosis in Human Cancer Cells via Glutathione Depletion and Sustained Activation of the Epidermal Growth Factor Receptor, Src, JNK, and p38 MAPK

Cuadrado, A., García‐Fernández, L., González, L., Suárez, Y., Losada, A., Alcaide, V., Martı́nez, T., Fernández-Sousa, J. M., Sánchez-Puelles, J.-M., & Múñoz, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201010200 · Cited by 157

Arenastatin A, a potent cytotoxic depsipeptide from the Okinawan marine sponge Dysidea arenaria

Kobayashi, M., Aoki, S., Ohyabu, N., Kurosu, M., Wang, W., & Kitagawa, I. (1994) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)78398-5 · Cited by 155

Progress in the Chemistry of Organic Natural Products.

Harbörne, J. B. (1976) · Phytochemistry · doi:10.1016/s0031-9422(00)84429-5 · Cited by 154

Natural products as probes of cell biology: 20 years of didemnin research

Vera, M. D., & Joullié, M. M. (2002) · Medicinal Research Reviews · doi:10.1002/med.10003 · Cited by 153

Isolation and structure of the cytostatic linear depsipeptide dolastatin 15

Pettit, G. R., Kamano, Y., Dufresne, C., Cerny, R. L., Herald, C. L., & Schmidt, J. M. (1989) · The Journal of Organic Chemistry · doi:10.1021/jo00287a003 · Cited by 151

Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4

Broggini, M., Marchini, S., Galliera, E., Borsotti, P., Taraboletti, G., Erba, E., Sironi, M., Jimeno, J. M., Faircloth, G. T., Giavazzi, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402788 · Cited by 151

Structure−Activity Relationships of the Didemnins

Sakai, R., Rinehart, K. L., Kishore, V., Kundu, B. K., Faircloth, G. T., Gloer, J. B., Carney, J. R., Namikoshi, M., Sun, F.-R., Hughes, R. G., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960048g · Cited by 150

Progress in the development and acquisition of anticancer agents from marine sources

Amador, M. L., Jimeno, J. M., Paz-Ares, L. G., Cortés-Funes, H., & Hidalgo, M. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg443 · Cited by 150

The marine compound spisulosine, an inhibitor of cell proliferation, promotes the disassembly of actin stress fibers

Cuadros, R., de Garcini, E. M., Wandosell, F. G., Faircloth, G. T., Fernández-Sousa, J. M., & Ávila, J. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00428-0 · Cited by 147

Total synthesis of the immunosuppressive agent (-)-discodermolide

Nerenberg, J. B., Hung, D. T., Somers, P. K., & Schreiber, S. L. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00079a066 · Cited by 145

Dictyodendrins A−E, the First Telomerase-Inhibitory Marine Natural Products from the Sponge Dictyodendrilla verongiformis1

Warabi, K., Matsunaga, S., van Soest, R. W. M., & Fusetani, N. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo0267910 · Cited by 143

Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates

Urdiales, J. L., Morata, P., de Castro, I. N., & Sánchez‐Jiménez, F. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04151-1 · Cited by 142

Synthesis and Structure Determination of Kahalalide F1,2

López-Macià, À., Jiménez, J. C., Royo, M., et al. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0116728 · Cited by 141

A New Antitumor Isoquinoline Alkaloid from the Marine Nudibranch Jorunna funebris

Fontana, A., Cavaliere, P., Wahidulla, S., Naik, C. G., & Cimino, G. (2000) · Tetrahedron · doi:10.1016/s0040-4020(00)00629-3 · Cited by 141

GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1 alpha.

Crews, C. M., Collins, J. L., Lane, W. S., Snapper, M. L., & Schreiber, S. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40692-2 · Cited by 140

Brominated tyrosine metabolites from an unidentified sponge

Arabshahi, L., & Schmitz, F. J. (1987) · The Journal of Organic Chemistry · doi:10.1021/jo00392a016 · Cited by 130

N-Hydroxy-3-phenyl-2-propenamides as Novel Inhibitors of Human Histone Deacetylase with in Vivo Antitumor Activity: Discovery of (2E)-N-Hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)

Remiszewski, S., Sambucetti, L. C., Bair, K. W., Bontempo, J., Cesarz, D., Chandramouli, N., Chen, R., Cheung, M., Cornell-Kennon, S., Dean, K., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030235w · Cited by 130

Aquaculture of three phyla of marine invertebrates to yield bioactive metabolites: process developments and economics

Mendola, D. (2003) · Biomolecular Engineering · doi:10.1016/s1389-0344(03)00075-3 · Cited by 130

Alkaloids from the antarctic sponge Kirkpatrickia varialosa. Part 2: Variolin A and N(3′)-methyl tetrahydrovariolin B

Trimurtulu, G., Faulkner, D. J., Perry, N. B., et al. (1994) · Tetrahedron · doi:10.1016/s0040-4020(01)89674-5 · Cited by 122

Molecular pharmacology of manoalide

Glaser, K. B., & Jacobs, R. S. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90218-2 · Cited by 117

Some pharmacological observations on marine natural products

Jacobs, R. S., Culver, P., Langdon, R. B., O'Brien, T., & White, S. (1985) · Tetrahedron · doi:10.1016/s0040-4020(01)96465-8 · Cited by 117

Diazonamide A and a Synthetic Structural Analog: Disruptive Effects on Mitosis and Cellular Microtubules and Analysis of Their Interactions with Tubulin

Cruz‐Monserrate, Z., Vervoort, H. C., Bai, R., Newman, D. J., Howell, S. B., Los, G., Mullaney, J. T., Williams, M. D., Pettit, G. R., Fenical, W., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1273 · Cited by 117

The design, computer modeling, solution structure, and biological evaluation of synthetic analogs of bryostatin 1

Wender, P. A., Brabander, J. K. D., Harran, P. G., Jimenez, J., Koehler, M. F. T., Lippa, B., Park, C., Siedenbiedel, C., & Pettit, G. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6624 · Cited by 111

The antitumoral compound Kahalalide F acts on cell lysosomes

Garcı́a-Rocha, M., Bonay, P., & Ávila, J. (1996) · Cancer Letters · doi:10.1016/0304-3835(95)04036-6 · Cited by 103

Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp. and Siphonochalina spp. sponges

Gamble, W. R., Durso, N. A., Fuller, R. W., Westergaard, C. K., Johnson, T. R., Sackett, D. L., Hamel, E., Cardellina, J. H., & Boyd, M. R. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00089-9 · Cited by 98

Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma

Laverdière, C., Kolb, E. A., Supko, J. G., Gorlick, R. G., Meyers, P. A., Maki, R. G., Wexler, L. H., Demetri, G. D., Healey, J. H., Huvos, A. G., et al. (2003) · Cancer · doi:10.1002/cncr.11563 · Cited by 98

Marine-derived anticancer agents in clinical trials

Schwartsmann, G., da Rocha, A. B., Mattei, J., & Lopes, R. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.8.1367 · Cited by 95

Synthesis and Biological Evaluation of a Focused Mixture Library of Analogues of the Antimitotic Marine Natural Product Curacin A

Wipf, P., Reeves, J. T., Balachandran, R., Giuliano, K. A., Hamel, E., & Day, B. W. (2000) · Journal of the American Chemical Society · doi:10.1021/ja002213u · Cited by 92

Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the vinca alkaloids, and dolastatin 10

Edler, M., Fernandez, A. M., Lassota, P., Ireland, C. M., & Barrows, L. R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00898-x · Cited by 92

Cdc6 cooperates with Sic1 and Hct1 to inactivate mitotic cyclin-dependent kinases

Calzada, A., Sacristán, M. P., Sánchez, E., et al. (2001) · Nature · doi:10.1038/35085610 · Cited by 90

The combination of yondelis and cisplatin is synergistic against human tumor xenografts

D’Incalci, M., Colombo, T., Ubezio, P., Nicoletti, I., Giavazzi, R., Erba, E., Ferrarese, L., Meco, D., Riccardi, R., Sessa, C., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00490-8 · Cited by 90

The Discovery of NVP-LAQ824: From Concept to Clinic

Remiszewski, S. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456675 · Cited by 88

Yondelis® (trabectedin, ET-743): the development of an anticancer agent of marine origin

van Kesteren, C., de Vooght, M. M. M., Lázaro, L. L., Mathôt, R. A. A., Schellens, J. H. M., Jimeno, J. M., & Beijnen, J. H. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200308000-00001 · Cited by 88

The molecular pharmacology of symplostatin 1: A new antimitotic dolastatin 10 analog

Mooberry, S. L., Leal, R. M., Tinley, T. L., Luesch, H., Moore, R. E., & Corbett, T. H. (2003) · International Journal of Cancer · doi:10.1002/ijc.10982 · Cited by 87

Phase I and pharmacokinetic study of Yondelis™ (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours

Twelves, C. J., Hoekman, K., Bowman, A., Vermorken, J. B., Anthoney, A., Smyth, J., van Kesteren, C., Beijnen, J. H., Uiters, J., Wanders, J., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00458-1 · Cited by 84

The relationship between Taxol and (+)-discodermolide: synthetic analogs and modeling studies

Martello, L. A., LaMarche, M. J., He, L., Beauchamp, T. J., Smith, A. B., & Horwitz, S. B. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00055-2 · Cited by 83

Bengamides Revisited: New Structures and Antitumor Studies

Thale, Z. I., Kinder, F. R. J., Bair, K. W., Bontempo, J., Czuchta, A. M., Versace, R. W., Phillips, P. E., Sanders, M. L., Wattanasin, S., & Crews, P. (2001) · The Journal of Organic Chemistry · doi:10.1021/jo001380+ · Cited by 83

Dolastatin-10 in Metastatic Melanoma: A Phase II and Pharmokinetic Trial of the California Cancer Consortium

Margolin, K. A., Longmate, J., Synold, T. W., Gandara, D. R., Weber, J. S., Gonzalez, R. C., Johansen, M. J., Newman, R. A., Baratta, T., & Doroshow, J. H. (2001) · Investigational New Drugs · doi:10.1023/a:1010626230081 · Cited by 82

The clinical development of the bryostatins

Clamp, A. R., & Jayson, G. C. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200208000-00001 · Cited by 82

Isolation of Four New Cyclic Depsipeptides, Antanapeptins A−D, and Dolastatin 16 from a Madagascan Collection of Lyngbya majuscula

Nogle, L. M., & Gerwick, W. H. (2001) · Journal of Natural Products · doi:10.1021/np010348n · Cited by 79

The inefficiency of incisions of ecteinascidin 743–DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent

Zewail‐Foote, M., LI, V. ‐., Kohn, H., Bearss, D. J., Guzman, M., & Hurley, L. H. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00071-0 · Cited by 79

Contignasterol, a highly oxygenated steroid with the unnatural 14.beta. configuration from the marine sponge Petrosia contignata Thiele, 1899

Burgoyne, D. L., Andersen, R. J., & Allen, T. M. (1992) · The Journal of Organic Chemistry · doi:10.1021/jo00028a024 · Cited by 75

Cryptophycins: A Novel Class of Potent Antimitotic Antitumor Depsipeptides

Shih, C., & Teicher, B. A. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397474 · Cited by 74

Pharmaceutical development of anticancer agents derived from marine sources

Nuijen, B., Bouma, M., Manada, C., Jimeno, J. M., Schellens, J. H. M., Bult, A., & Beijnen, J. H. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200011000-00003 · Cited by 71

DISCODERMOLIDE—A NEW, MARINE-DERIVED IMMUNOSUPPRESSIVE COMPOUND

Longley, R. E., CADDIGAN, D., Harmody, D. K., Gunasekera, M., & Gunasekera, S. P. (1991) · Transplantation · doi:10.1097/00007890-199110000-00015 · Cited by 71

Interaction of halichondrin B and homohalichondrin B with bovine brain tubulin

Ludueña, R. F., Roach, M. C., Prasad, V., & Pettit, G. R. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90079-c · Cited by 70

The luffariellins, novel antiinflammatory sesterterpenes of chemotaxonomic importance from the marine sponge Luffariella variabilis

Kernan, M. R., Faulkner, D. J., & Jacobs, R. S. (1987) · The Journal of Organic Chemistry · doi:10.1021/jo00390a021 · Cited by 68

Fulfilling the promise of biotechnology

Colwell, R. R. (2002) · Biotechnology Advances · doi:10.1016/s0734-9750(02)00011-3 · Cited by 64

In vitro inactivation of the neurotoxic action of β-bungarotoxin by the marine natural product, manoalide

de Freitas, J. C., Blankemeier, L. A., & Jacobs, R. S. (1984) · Cellular and Molecular Life Sciences · doi:10.1007/bf01951998 · Cited by 63

Phase-trafficking reagents and phase-switching strategies for parallel synthesis

Flynn, D. L. (1999) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199909)19:5<388::aid-med6>3.0.co;2-h · Cited by 61

Marine Natural Products as Lead Anti-HIV Agents

Gochfeld, D. J., Sayed, K. A. E., Yousaf, M., Hu, J., Bartyzel, P., Dunbar, D. C., Wilkins, S. P., Zjawiony, J. K., Schinazi, R. F., & Wirtz, S. S. (2003) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557033487962 · Cited by 59

Neovastat—a novel antiangiogenic drug for cancer therapy

Gingras, D., Boivin, D., Deckers, C., Gendron, S. P., Barthomeuf, C., & Béliveau, R. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200302000-00001 · Cited by 57

Inactivation of bee venom phospholipase A2 by manoalide

Glaser, K. B., & Jacobs, R. S. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90134-1 · Cited by 56

Peptides with anticancer use or potential

Janin, Y. L. (2003) · Amino Acids · doi:10.1007/s00726-002-0349-x · Cited by 56

Immunosuppression by Discodermolide

Longley, R. E., Gunasekera, S. P., Faherty, D. A., McLane, J. A., & Dumont, F. J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb17145.x · Cited by 54

Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer

Kerbrat, P., Dieras, V. C., Pavlidis, N. A., Ravaud, A., Wanders, J., & Fumoleau, P. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00531-2 · Cited by 53

Stereochemistry of Kahalalide F

Bonnard, I., Manzanares, I., & RINEHART, K. L. J. (2003) · Journal of Natural Products · doi:10.1021/np030334c · Cited by 53

The anti-neoplastic and novel topoisomerase II-mediated cytotoxicity of neoamphimedine, a marine pyridoacridine

Marshall, K. M., Matsumoto, S. S., Holden, J. A., Concepción, G. P., Taşdemir, D., Ireland, C. M., & Barrows, L. R. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00209-0 · Cited by 52

Effect of Contignasterol on Histamine Release Induced by Anti-Immunoglobuline from Rat Peritoneal Mast Cells

Takei, M., Burgoyne, D. L., & Andersen, R. J. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830909 · Cited by 50

Cytoskeleton in the cell cycle

Nakaseko, Y., & Yanagida, M. (2001) · Nature · doi:10.1038/35085684 · Cited by 49

Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel–Dreyer chromatography

Cruz‐Monserrate, Z., Mullaney, J. T., Harran, P. G., Pettit, G. R., & Hamel, E. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03776.x · Cited by 49

Unique Features of the Mode of Action of ET-743

D’Incalci, M., Erba, E., Damia, G. L. M., Galliera, E., Carrassa, L., Marchini, S., Mantovani, R., Tognon, G., Fruscio, R., Jimeno, J. M., et al. (2002) · The Oncologist · doi:10.1634/theoncologist.7-3-210 · Cited by 46

Interactions of antimitotic peptides and depsipeptides with tubulin

Hamel, E. (2002) · Biopolymers · doi:10.1002/bip.10255 · Cited by 45

A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer

Winegarden, J. A. (2003) · Lung Cancer · doi:10.1016/s0169-5002(02)00447-6 · Cited by 42

Effects of arenastatin A and its synthetic analogs on microtubule assembly

Koiso, Y., Morita, K., Kobayashi, M., Wang, W., Ohyabu, N., & Iwasaki, S. (1996) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(96)03743-x · Cited by 41

Pharmacokinetics and urinary excretion of DMXBA (GTS-21), a compound enhancing cognition

Mahnir, V. M., Lin, B., Prókai-Tátrai, K., & Kem, W. R. (1998) · Biopharmaceutics & Drug Disposition · Cited by 40

AE-941, a multifunctional antiangiogenic compound: trials in renal cell carcinoma

Bukowski, R. M. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.8.1403 · Cited by 36

Activity of the dolastatin analogue, LU103793, in malignant melanoma

Smyth, J., Bonneterre, M.-E., Schellens, J. H. M., Calvert, H., Greim, G., Wanders, J., & Hanauske, A. (2001) · Annals of Oncology · doi:10.1023/a:1011194910571 · Cited by 36

Effects of IZP‐94005 (contignasterol) on antigen‐induced bronchial responsiveness in ovalbumin‐sensitized guinea‐pigs

Bramley, A. M., Langlands, J. M., Jones, A. K., et al. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16634.x · Cited by 35

In vitro toxicity of three new antitumoral drugs (trabectedin, aplidin, and kahalalide F) on hematopoietic progenitors and stem cells

Gómez, S. G., Bueren, J. A., Faircloth, G. T., Jimeno, J. M., & Albella, B. (2003) · Experimental Hematology · doi:10.1016/j.exphem.2003.07.004 · Cited by 35

Population pharmacokinetics of the novel anticancer agent KRN7000

Crul, M., Mathôt, R. A. A., Giaccone, G., Punt, C. J. A., Rosing, H., Hillebrand, M. J. X., Ando, Y., Nishi, N., Tanaka, H., Schellens, J. H. M., et al. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-001-0413-3 · Cited by 31

Cell-Based Screen for Identification of Inhibitors of Tubulin Polymerization

Kokoshka, J. M., Ireland, C. M., & Barrows, L. R. (1996) · Journal of Natural Products · doi:10.1021/np960144k · Cited by 15

Commentary re: Q-T Le et al, identification of osteopontin as a prognostic marker for head and neck squamous cell carcinomas. clin cancer res, 9: 31-32, 2003.

Denhardt, D. T. (2003) · PubMed · Cited by 1

Untitled work

Rinehart (2000) · doi:10.1002/(sici)1098-1128(200001)20:1<1::aid-med1>3.0.co;2-a

Marine natural products

Faulkner, D. J. (1990) · Natural Product Reports · doi:10.1039/np9900700269 · Cited by 4,866

The Biodiversity of the Mediterranean Sea: Estimates, Patterns, and Threats

Coll, M., Piroddi, C., Steenbeek, J., Kaschner, K., Ben Rais Lasram, F., Aguzzi, J., Ballesteros, E., Bianchi, C. N., Corbera, J., Dailianis, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011842 · Cited by 2,155

Developing a new resource for drug discovery: marine actinomycete bacteria

Fenical, W., & Jensen, P. R. (2006) · Nature Chemical Biology · doi:10.1038/nchembio841 · Cited by 786

Marine natural products as anticancer drugs

Simmons, T. L., Andrianasolo, E., McPhail, K., Flatt, P., & Gerwick, W. H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.333.4.2 · Cited by 597

Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni , the cyanobacterial symbiont of Lissoclinum patella

Schmidt, E. W., Nelson, J. T., Rasko, D. A., Sudek, S., Eisen, J. A., Haygood, M. G., & Ravel, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501424102 · Cited by 567